1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow ARRY-371797: new trials by email Literature Review of ARRY-371797 trials Research Report on ARRY-371797
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation ARRY-371797 (PF-07265803), Placebo - Dilated Cardiomyopathy, Lamin A/C Gene Mutation | Phase 3 | Terminated | Pfizer | 77 | 2018-04-17 | 2024-01-09 |
Cardiomyopathies (1) · Cardiomyopathy, Dilated (1) · Heart Failure (1) · Limb-girdle muscular dystrophy, type 1B (1)
Pfizer (1)
Argentina (1) · Belgium (1) · Canada (1) · Italy (1) · Mexico (1) · Netherlands (1) · Norway (1) · Spain (1) · United Kingdom (1) · United States (1)
PMID 36718638, PMID 37010012, PMID 38979608, PMID 39145700, PMID 41693767
2017 (1)